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Abstract
Objective: This study analyzes differences between HIV statistics in Hispanic American
countries that have passed UHC legislation versus those that have not passed UHC legislation. In
2017, 0.4% of the population of Latin America and 1.2% of the population of the Caribbean was
living with Human Immunodeficiency Virus (HIV).1 Because of these high rates of HIV in
Hispanic America, as well as the lethality of HIV if untreated, HIV statistics and treatment
outcomes in Hispanic America are of great concern. Relationships between HIV statistics and
Universal Health Coverage (UHC) legislation could serve as a metric for UHC performance in
Hispanic American countries. Methods: The HIV statistics analyzed are HIV prevalence, HIV
incidence, number of acquired immune deficiency syndrome (AIDS) related deaths, percent of
people with HIV receiving anti-retroviral therapy (ART), 12-month retention on ART, motherto-child HIV transmission rate, percent of people living with HIV whose deaths were averted due
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to ART, and percent of people living with HIV who have suppressed viral loads. HIV/AIDS data
for this study was found from UNAIDS,1 and the UHC legislation data was found from WHO’s
Global Health Observatory.2 Data was analyzed with independent t-tests to compare HIV
statistics in countries that have passed UHC legislation versus those that have not passed UHC
legislation. Results: Countries that have passed UHC legislation have significantly higher
prevalence (p = .04) and incidence (p = .02) of HIV than countries that have not passed UHC
legislation. Countries that have passed UHC legislation have significantly less deaths due to
AIDS (p = .03).

Key Words:
Human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), Hispanic
America, universal health coverage (UHC)

Frantz 3
Introduction/Literature Review
In Latin America, 1,900,000 people [1,500,000-2,300,000], or 0.4% [0.3%-0.5%] of the
population, were living with HIV in 2017.1 In the Caribbean in 2017, 330,000 people [280,000390,000], or 1.2% [1.0%-1.4%] of the population, were living with HIV.1 Because of these high
rates of HIV in Hispanic America, as well as the lethality of HIV if untreated, HIV rates and
treatment outcomes in Hispanic America are of great concern. HIV causes a decrease in the
number of CD4+ T cells, which leads to increased risk of infections and cancer.3 Opportunistic
infections that take place among HIV patients with decreased CD4+ counts are often the cause of
death for HIV patients, but opportunistic infections and AIDS-related deaths are often
preventable with modern antiretroviral therapy (ART).
Upon review of the literature, we did not find any studies examining the relationship between
UHC legislation and HIV outcomes; as such, this study bridges a gap in our understanding of the
relationship between HIV outcomes and universal health coverage legislation. Nonetheless,
related research indicates that increased insurance coverage and government spending on health
lead to improved outcomes. Use of medical services increases among people with higher level of
insurance coverage.4-6 Increased use of medical services may improve patient outcomes due to
increased consultation and intervention from healthcare professionals, as well as preventative
care. In a study on a health insurance program for impoverished Colombians, increased use of
preventative care through the program led to fewer sick days and fewer ill symptoms in pediatric
patients.7 UHC allows for improved access to preventative care, so UHC legislation may produce
similar results as the Colombian health insurance program study. In addition, population health
outcomes tend to be better in countries with higher government spending and increased pooled
health financing,8-10 suggesting that UHC could improve population health outcomes. Therefore,
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we hypothesized that countries that have passed UHC legislation would have more favorable
HIV outcomes, such as lower HIV prevalence and incidence, fewer AIDS-related deaths, higher
percent of HIV patients receiving ART, higher retention in ART, lower mother-to-child
transmission rate, more deaths averted due to ART, and a higher percent of patients with
suppressed viral load.
Hypothesis/Specific Aims/Research Questions
The eight research questions addressed in this project are listed below.
1. How does UHC legislation in Hispanic American countries affect the percent of
population living with HIV?
2. How does UHC legislation in Hispanic American countries affect incidence of HIV?
3. How does UHC legislation in Hispanic American countries affect the percent people
living with HIV that die AIDS-related deaths?
4. How does UHC legislation in Hispanic American countries affect the number of people
on ART?
5. How does UHC legislation in Hispanic American countries affect 12-month retention on
antiretroviral therapy?
6. How does UHC legislation in Hispanic American countries affect mother-to-child HIV
transmission rate?
7. How does UHC legislation in Hispanic American countries affect number of deaths
averted due to ART?
8. How does UHC legislation in Hispanic American countries affect percent of people
living with HIV who have suppressed viral loads?
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Methods
Context
HIV/AIDS data for this study was found from UNAIDS,1 and the Universal Health Coverage
data was found from WHO’s Global Health Observatory.2 Due to data being derived from
publicly available data sets, IRB approval was not required.
UNAIDS develops their HIV/AIDS estimates with teams consisting of epidemiologists,
demographers, monitoring and evaluation specialists, and technical partners.11 The software used
by UNAIDS to create estimate models are Spectrum from Avenir Health and the Estimates and
Projections Package from East-West Center.11 In countries of high rates of HIV transmission,
HIV prevalence estimates are gathered from nationally representative population-based surveys
and antenatal clinic attendance surveillance. In countries of low-level HIV epidemic, estimates
are gathered from empirical data about high-risk populations. Surveys and data of pregnant
women who attend antenatal clinics are used for determining estimates of HIV prevalence
among low-risk populations within these low-level HIV epidemic countries. Countries in Latin
America and the Caribbean have insufficient antenatal clinic surveillance data and populationbased survey data, so data is gathered from registration and disease reporting systems. In these
countries, HIV case reports and data on AIDS-related deaths are used directly to determine
estimates.11
The WHO Global Health Observatory data on countries that have passed UHC legislation
was gathered from a 2013 study by Feigl and Ding.12 This study used databases and legal
healthcare documents to collect data. Feigl and Ding developed a new indicator to classify
countries with universal health coverage and called this indicator “evidenced formal coverage”

Frantz 6
(EFC). Countries qualified as having EFC if they had legislated UHC, had a formal coverage rate
of ≥85%, and had ≥90% access to skilled attendance at birth.12 This study considers the first
passage of any UHC legislation to be the marker of UHC coverage, but most countries do not
convert to a completely UHC health system with the passage of the first UHC-related legislation.
Percent of population with healthcare coverage was determined from two International Labor
Office reports.12 To determine whether countries had passed UHC legislation, Feigl and Ding
searched databases and healthcare legal documents of governments of the countries studied. If
the legislation included language that indicated that all citizens were covered by the health plan,
the researchers determined that the country had legal coverage.12
Data Collection
We chose to analyze the HIV statistics and UHC legislation in Hispanic America. Hispanic
America consists of the predominantly Spanish-speaking countries of Latin America and the
Caribbean. These countries include Argentina, Bolivia, Chile, Colombia, Costa Rica, Cuba, the
Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama,
Paraguay, Peru, Puerto Rico, Uruguay, and Venezuela.
Not all countries included in the study had complete data for every variable. Any country that
lacked a data point for a given variable was excluded from analysis of that variable. Puerto Rico
lacked data for all variables and was excluded from the entire study. Nineteen countries were
included in this study.
Data Analysis
We conducted independent t-tests for each of the eight research questions to compare
HIV statistics in Hispanic American countries that have passed UHC legislation versus those
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that have not passed UHC legislation. The independent variables were presence or absence of
UHC legislation, so countries were split into groups “yes” (those that have passed UHC
legislation) and “no” (those that have not passed UHC legislation). The dependent variables
were HIV prevalence (%), HIV incidence (per 1000 population), percent of those living with
HIV who died AIDS-related deaths, percent of people living with HIV whose deaths were
averted due to ART, percent of people living with HIV receiving ART, mother-to-child
transmission rate, 12-month retention on ART (%), and percent of people living with HIV
who have suppressed viral load. Hispanic American countries that have passed UHC
legislation are Argentina, Bolivia, Chile, Colombia, Costa Rica, Cuba, Dominican Republic,
Ecuador, Panama, El Salvador, Uruguay, and Venezuela. Hispanic American countries that
have not passed UHC legislation are Guatemala, Honduras, Mexico, Nicaragua, Peru, and
Paraguay.

Results
The mean prevalence was significantly higher in countries that have passed UHC legislation
(Table; mean “yes UHC” 0.527%; mean “no UHC” 0.317%; p = .04). The mean incidence of
HIV diagnoses per 1000 people in the population was also significantly higher in countries that
have passed UHC legislation (Table; mean “yes UHC” 0.346; mean “no UHC” 0.173; p = .02).
The mean percent of people living with HIV who died due to AIDS-related deaths was
significantly lower in countries that have passed UHC (Table; mean “yes UHC” 0.019; mean “no
UHC” 0.033; p = .03).
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Table: HIV Outcomes and UHC Legislation

UHC legislation*

N**

Mean

Std. Deviation

P value

HIV Prevalence (%)

Yes

11

0.527***

0.205

.04

HIV Incidence per 1000 Population

No
Yes

6
11

0.317
0.346***

0.117
0.151

.02

No
Yes

6
9

0.173
0.019***

0.077
0.007

.03

No

5

0.033

0.015

Percent of People Living with HIV
whose Deaths were Averted due to ART

Yes

9

0.033

0.008

No

5

0.032

0.012

Percent of People Living with HIV
Receiving ART

Yes

11

51.82

8.097

No

6

49.67

11.501

Mother-to-Child Transmission Rate

Yes

10

12.103

6.363

No

6

17.630

6.774

Yes

6

81.670

15.629

No

5

71.600

18.929

Yes

5

35.800

7.887

No

4

37.750

10.436

Percent of People Living with HIV who
Died AIDS-Related Deaths

12 Month Retention on ART (%)
Percent of People Living with HIV with
Suppressed Viral Load

Legend for Table:
* UHC legislation, Yes: countries that have passed UHC legislation;
UHC legislation, No: countries that have not passed UHC legislation
** N: Number of countries included for analysis
*** Significantly different from countries with no UHC legislation (p < .05)
Data adapted from UNAIDS2 and WHO’s Global Health Observatory2

Discussion
There was a statistically significant difference in mean HIV prevalence, incidence, and
AIDS-related deaths in Hispanic American countries that have passed UHC legislation compared

.85

.66

.12
.36
.76
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to Hispanic American countries that have not passed UHC legislation. Two of the three
statistically significant results refuted our hypothesis that countries that have passed UHC
legislation would have more favorable HIV outcomes. We hypothesized that countries that had
passed UHC legislation would have lower prevalence and incidence of HIV than countries that
have not passed UHC legislation, but the data refute this hypothesis. Instead, countries that have
passed UHC legislation have statistically significantly higher prevalence and incidence of HIV
(Table). The data support our hypothesis that there are fewer AIDS-related deaths among HIV
patients in countries that have passed UHC legislation (Table). No statistically significant
differences were found for mean deaths averted due to ART, percent of people living with HIV
receiving ART, mother-to-child transmission rate, 12-month retention on ART, or percent of
people living with HIV who have suppressed viral load (Table). Further research is needed to
understand why Hispanic American countries with UHC legislation had higher prevalence and
incidence of HIV. One potential consideration for decreased prevalence and incidence of HIV in
countries without UHC legislation may be that decreased insurance coverage and healthcare
access leads to decreased rates of testing for HIV, resulting in underreported prevalence and
incidence of HIV.
The data suggest that universal health coverage legislation does not have a positive impact on
HIV outcomes, except that it may lead to decreased AIDS-related deaths among HIV patients.
Our findings contradict the current literature, which suggests that increased insurance coverage
leads to increased medical service use, fewer sick days, and improved public health
outcomes.4,7,8
A major limitation faced in this study was lack of availability of data. Some countries did not
have data available for various data points. Venezuela had a lack of data for many of the research
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questions investigated in this study. Although there were 19 countries included in this study, only
as many as 17 countries had data on a given statistic, such as prevalence, and as few as only 9 of
the 19 countries had available data for percent of HIV patients with suppressed viral load.
Another limitation faced in this study was an incomplete understanding of universal health
coverage in each country. The study that we used to provide UHC legislation data considered a
country to have UHC if there had been any legislation indicating any level of UHC; there is
likely a discrepancy in amount of coverage between countries. It was not feasible to quantify
ease of access in each country, percent of the population that had coverage through each
country’s UHC plan, or what medical services that the UHC plan covered.
Future research should further investigate the relationship between UHC legislation and HIV
outcomes, since the results from this study and findings from other studies about increased
insurance coverage are contradictory. Other related future directions include investigating HIV
outcomes compared to prevalence of homophobia and HIV stigma in various locations
worldwide.
Conclusion
Countries with UHC legislation have significantly fewer deaths due to AIDS (p = .03), but
prevalence and incidence of HIV are significantly higher in countries with UHC legislation (p =
.04 and p = .02, respectively). Some research indicates improved health outcomes with increased
insurance coverage or government health spending,4,7,8 suggesting a potential link between UHC
legislation and health outcomes. Since HIV is highly prevalent in Hispanic America,
investigating the relationship between UHC legislation and HIV outcomes could serve as a
metric for performance of UHC legislation. This could shape health policymaking, but more
investigation is needed.
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